Applying Guideline-Recommended and Recent Evidence-Based Therapies in the Treatment of Chronic Heart Failure

 
Release Date: April 17, 2017
Last Reviewed: March 19, 2017
Expiration Date: April 17, 2018
Time to Complete Activity: 1.0 hour
 
Faculty
JoAnn Lindenfeld, MD (Chair)
Professor of Medicine
Director, Heart Failure and Transplant Section
Vanderbilt University
Nashville, TN
 
Mark E. Dunlap, MD
Professor of Medicine, Physiology, and Biophysics
Case Western Reserve University
Director, Heart Failure Section
Heart and Vascular Center
The MetroHealth System
Cleveland, OH
 
Herb Patterson, PharmD
Professor of Pharmacy
Research Professor of Medicine
Eshelman School of Pharmacy
University of North Carolina
Chapel Hill, NC

This activity is provided by Paradigm Medical Communications, LLC. 

In collaboration with the Hospital Quality Foundation.

Target Audience
This activity has been designed to address the educational needs of physicians specializing in cardiology, interventional cardiology, heart failure, internal medicine, hospital medicine, pulmonary medicine, emergency medicine, and primary care. This activity will also be of benefit to nurse practitioners, PAs, and other clinicians interested in the management of chronic heart failure.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Describe the underlying pathophysiology of chronic heart failure, including differentiation between heart failure with reduced or preserved left ventricular ejection fraction.
  • Review the 2013 ACCF/AHA heart failure guidelines and the basis for the recommendations along with the 2016 ACC/AHA/HFSA update to the guidelines.
  • Describe the background information supporting the 2016 guideline update including mechanisms of action, clinical evidence for, and appropriate use of newer heart failure therapies.
     
TABLE OF CONTENTS
Chapter 1: Introduction to Chronic Heart Failure
Chapter 2: Pathophysiology of Chronic Heart Failure 
Chapter 3: Guideline Recommendations for Management of Chronic Heart Failure
Chapter 4: Recently Approved Agents for Management of Chronic Heart Failure
Chapter 5: Tying it All Together  
 
Physician Accreditation Statement
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
PA Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 Category 1 credit for completing this activity.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 
Disclosure of Commercial Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
 
Instructions for Participation
To receive a CME certificate of participation, you should:
  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
 
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
 
There is no fee required for participation in this activity.
 
Hardware/Software Requirements
This certified CME activity is designed using HTML5 audio.
 
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
 
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.
 
Disclosures
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty
JoAnn Lindenfeld, MD (Chair)
Retained Consultant: Abbott, CVRx, Edwards Lifesciences Corporation, Novartis, Relypsa Inc., ResMed, V-Wave Ltd.

Mark E. Dunlap, MD
No financial relationships to disclose
 
Herb Patterson, PharmD
Grant/Research Support: Novartis; Otsuka America Pharmaceutical, Inc.
Retained Consultant: Amgen Inc.; Novartis  
 
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, independent, fairly balanced, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website”) located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
©2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.